Answers are grounded in this paper and cite their sources.
Examines JAK2V617F mutation prevalence in BRCA1 and BRCA2 mutation carriers, suggesting inherited mutation links.
Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell disorders characterized by excessive proliferation of one or more myeloid lineages [ 1 ]. The JAK2 V617F mutation, resulting in constitutive JAK-STAT activation, represents the most frequent driver event and is a key diagnostic criterion in MPN [ 1 ]. While most cases arise sporadically, familial clustering accounts for approximately 7% of diagnoses [ 2 ], suggesting an inherited predisposition facilitating the acquisition of somatic driver mutations such as JAK2 V617F .
No takes yet. Share an insight, caveat, or question.
Rodriguez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: